Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
April 6, 2013
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
J Szkandera, G Absenger, B Liegl-Atzwanger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 26, 1999
A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer
H Samonigg, M Wilders-Truschnig, I Kuss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer
P Birner, G Oberhuber, J Stani, et al.
British Journal of Cancer
|
April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
F Fitzal, M Filipits, M Rudas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study Group
R Jakesz, H Samonigg, M Gnant, et al.
British Journal of Cancer
|
April 21, 2011
Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck
T Bauernhofer, M Pichler, E Wieckowski, et al.
British Journal of Cancer
|
October 3, 2013
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
J Szkandera, A Gerger, B Liegl-Atzwanger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 26, 2013
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients
A C Regierer, R Wolters, M-P Ufen, et al.
The Pharmacogenomics Journal
|
April 10, 2013
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy
G Absenger, L Benhaim, J Szkandera, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
August 22, 2007
The Genome Austria Tissue Bank (GATiB)
M Asslaber, P M Abuja, K Stark, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
April 6, 2013
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
J Szkandera, G Absenger, B Liegl-Atzwanger, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 26, 1999
A double-blind randomized-phase II trial comparing immunization with antiidiotype goat antibody vaccine SCV 106 versus unspecific goat antibodies in patients with metastatic colorectal cancer
H Samonigg, M Wilders-Truschnig, I Kuss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer
P Birner, G Oberhuber, J Stani, et al.
British Journal of Cancer
|
April 14, 2015
The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
F Fitzal, M Filipits, M Rudas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study Group
R Jakesz, H Samonigg, M Gnant, et al.
British Journal of Cancer
|
April 21, 2011
Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck
T Bauernhofer, M Pichler, E Wieckowski, et al.
British Journal of Cancer
|
October 3, 2013
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
J Szkandera, A Gerger, B Liegl-Atzwanger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 26, 2013
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients
A C Regierer, R Wolters, M-P Ufen, et al.
The Pharmacogenomics Journal
|
April 10, 2013
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy
G Absenger, L Benhaim, J Szkandera, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
August 22, 2007
The Genome Austria Tissue Bank (GATiB)
M Asslaber, P M Abuja, K Stark, et al.
Page
of 8